The Tarrytown, New York-based company said it had net income of $8.06 per share. Earnings, adjusted for stock option expense and non-recurring costs, came to $12.07 per share. The results exceeded ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...
“This investment highlights our ongoing efforts to support and grow local economies, ensuring that New York and Regeneron continue to thrive together.” The Albany Business Review first ...
Seventeen high school students from 12 Westchester schools have been named semifinalists in the prestigious Regeneron Science Talent Search. They are among 300 students nationally recognized for ...
With a market cap of $77.3 billion, Regeneron Pharmaceuticals ... edge science to improve patient outcomes. The Tarrytown, New York-based company is expected to unveil its fiscal Q4 earnings ...